3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
46
Lung Neoplasms
29
Neoplasms
26
Colorectal Neoplasms
21
Prostatic Neoplasms
16
Uterine Cervical Neoplasms
9
Fatigue
9
Hematologic Neoplasms
8
Lymphoma
7
Hematopoietic and Lymphatic System Neoplasm
7
Anxiety Disorders
7
Papillomavirus Infections
6
Melanoma
6
Neoplasm Metastasis
5
Multiple Myeloma
5
Gastrointestinal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Urinary Bladder Neoplasms
4
Skin Neoplasms
4
Ovarian Neoplasms
4
Obesity-Related Malignant Neoplasm
4
Obesity
4
Motor Activity
4
Hematopoietic and Lymphoid System Neoplasm
4
Head and Neck Neoplasms
4
Depression
4
Breast Carcinoma In Situ
4
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Interventions
Paclitaxel
10
Surveys and Questionnaires
6
Cisplatin
6
Carboplatin
5
pembrolizumab
4
Brachytherapy
4
Hyperthermic Intraperitoneal Chemotherapy
3
Gemcitabine
3
Doxorubicin
3
Docetaxel
3
olaparib
2
niraparib
2
durvalumab
2
Topotecan
2
Taxes
2
Standard of Care
2
Sentinel Lymph Node Biopsy
2
Saline Solution
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Music Therapy
2
Mitomycin
2
Letrozole
2
Imagery, Psychotherapy
2
Hysterectomy
2
Exercise
2
Everolimus
2
Blood Specimen Collection
2
ulipristal acetate
1
temsirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Uterine Neoplasms
×
Educational Status
×
Clear all
NCT04679675
2023-09-18
STEP
Kaiser Permanente
Phase NA
Completed
32,771 enrolled
11 charts